GlobeVerge
A groundbreaking immunotherapy has been registered in South Africa for recurrent or metastatic nasopharyngeal carcinoma, a rare and aggressive cancer.
Developments like this can have effects beyond the immediate story. Directly involves South Africa, Meta.